RIMTERAVIMAB
UNII Z4LZB5VCU4

Substance Identification & Data

This profile provides standardized clinical and technical data for Rimteravimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z4LZB5VCU4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2540797-21-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z4LZB5VCU4
CAS Registry Number
2540797-21-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RIMTERAVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C183318
National Cancer Institute reference terminology for clinical and research data.
INN ID
12047
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rimteravimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RIMTERAVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN GAMMA1 VH-H-CH2-CH3 DIMER, ANTI-(RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE (S)GLYCOPROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROMECORONAVIRUS (SARS-COV) / SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2 (SARS-COV-2) / BAT SARSLIKE(BAT) CORONAVIRUS WIV1 (BAT SL-COV-WIV1)), MONOCLONAL ANTIBODY, BIVALENT
RIMTERAVIMAB [INN]
XVR 011 [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus